Ascariasis
📧 Sign up to get email alerts when something new happens for Ascariasis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-07FDA Approved: IVERMECTIN — Original Application (Ajanta Pharma USA Inc.)
FDA approved Ajanta Pharma USA Inc.'s original ANDA for ivermectin, making a generic version of the product available for human use. The app…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections [Phase 3]
A Phase 3 clinical trial update indicates a study of emodepside for soil-transmitted helminth infections is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections [Phase 3]
This clinical trial update notes a Phase 3 study evaluating the efficacy and safety of Emodepside for soil-transmitted helminth infections, …
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases [Phase 4]
Phase 4 clinical trial comparing moxidectin versus ivermectin for mass drug administration to control onchocerciasis and other neglected tro…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC [Phase 2]
Phase 2 study evaluating the efficacy, safety, and acceptability of an ivermectin orally disintegrating tablet in preschool-aged children fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC [Phase 3]
Phase 3 trial evaluating the efficacy and safety of co-administered moxidectin and albendazole for soil-transmitted helminth infections has …
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Efficacy and Safety of Oxantel Pamoate in Children Infected With Trichuris Trichiura [Phase 2]
Phase 2 trial evaluating the efficacy and safety of Oxantel Pamoate in children with Trichuriasis due to Trichuris trichiura, with data on c…
-
EMA guidance · 2025-01-31New combination of medicines to treat parasitic worm infections
EMA issued an opinion endorsing the use of a combination of ivermectin and albendazole to treat parasitic worm infections as part of global …
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Evaluating Impact of Improved Floors on Health [NA]
A completed clinical trial by the London School of Hygiene and Tropical Medicine evaluated whether improved flooring affects health outcomes…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Efficacy and Safety of MOX/ALB vs. IVM/ALB Co-administration [Phase 2, Phase 3]
Phase 2/3 trial comparing Moxidectin plus Albendazole versus Ivermectin plus Albendazole for helminth infections; results have been posted.
-
FDA approval · 2024-09-04FDA Approved: ALBENDAZOLE — Original Application (Alembic Pharmaceuticals Inc.)
FDA approves Alembic Pharmaceuticals' original application for albendazole, adding a generic version to the market.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Efficacy and Safety of MOX/ALB Co-administration [Phase 3]
Phase 3 trial assessing the efficacy and safety of co-administered MOX and ALB for parasitic worm infections; completed with results posted …
-
FDA approval · 2021-09-20FDA Approved: VERMOX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA issued a supplemental approval for Vermox (mebendazole) by Janssen Pharmaceuticals, expanding/updates its label.
-
FDA approval · 2021-01-26FDA Approved: ALBENDAZOLE — Original Application (Dr.Reddys Laboratories Inc)
FDA has approved Dr. Reddy's Laboratories Inc for albendazole under an Original Application, confirming the generic's authorization for list…
-
FDA approval · 2021-01-22FDA Approved: ALBENDAZOLE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original application for albendazole from Novadoz Pharmaceuticals LLC.
-
FDA approval · 2016-10-19FDA Approved: VERMOX — Original Application (Janssen Pharmaceuticals, Inc.)
FDA approved VERMOX (mebendazole) in Janssen's original application; indicated for treatment of common intestinal helminth infections.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children [NA]
A completed clinical trial assessing whether repeated anthelmintic treatment influences the risk of malaria in Kenyan schoolchildren.
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Monitoring the Efficacy of Anthelmintics for the Treatment of Soil Transmitted Helminths P2 [Phase 4]
Phase 4 clinical trial evaluating the efficacy of anthelmintics for soil-transmitted helminths, including Ascariasis, Trichuriasis, and Hook…
-
FDA approval · 2009-10-20FDA Approved: ALBENDAZOLE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for Albendazole submitted by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2008-04-17Clinical Trial Update: Efficacy Albendazole and Levamisole Against STH on Unguja [Phase 4]
Phase 4 clinical trial assessing the efficacy of albendazole and levamisole against soil-transmitted helminths in Unguja has completed. The …